Nan Fung Group Holdings »

Ascendis Pharma AS shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 14k 266.72

More positions owned by Nan Fung Group Holdings

Maplight Therapeutics (MPLT)
Lb Pharmaceuticals Com Shs (LBRX)
Evommune Com Shs (EVMN)
Cybin Com New (HELP)
Incyte Corporation (INCY)
Rhythm Pharmaceuticals (RYTM)
Beone Medicines Sponsored Ads (ONC)
Oculis Holding Ordinary Shares (OCS)
Ascendis Pharma A/s Ord Shs (ASND)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Madrigal Pharmaceuticals (MDGL)
Celcuity (CELC)
ACADIA Pharmaceuticals (ACAD)
Argenx Se Sponsored Adr (ARGX)

View all positions for Nan Fung Group Holdings

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS